New ALS drug stabilizes decline with a trend toward improved strength, mobility for some (Links to an external site)

Rickey Malloy (left), who receives tofersen treatment for SOD1-ALS at WashU Medicine, plays a round of golf with his wife, Jenny, and their son, Kash.

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline of neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington University School of Medicine in St. Louis and collaborators report that long-term use of tofersen, a new drug approved by the Food and Drug […]

Lee, Leuthardt awarded Falk Catalyst grant to fund acute stroke clinical trial

Headshots of Jin-Moo Lee and Eric Leuthardt

Jin-Moo Lee, MD, PhD, head of the WashU Medicine Department of Neurology, and Eric Leuthardt, MD, MBA, vice chair of innovation in the Department of Neurosurgery, have been selected as recipients of the prestigious Falk Catalyst Award. Each year, select institutions are invited to submit up to two applications to the Dr. Ralph and Marian […]

A Different Type of Dementia Is Changing What’s Known About Cognitive Decline (Links to an external site)

Doctors told Ray Hester he was in the beginning stages of Alzheimer’s, but a brain scan revealed he had LATE dementia. “There’s a certain amount of relief knowing that it’s not Alzheimer’s,” his wife, Sandy, said.

A recently recognized form of dementia is changing the understanding of cognitive decline, improving the ability to diagnose patients and underscoring the need for a wider array of treatments. Patients are increasingly being diagnosed with the condition, known as LATE, and guidelines advising doctors how to identify it were published this year. LATE is now estimated to […]

What if we can stop Alzheimer’s before it starts? (Links to an external site)

What if we could stop Alzheimer's before it starts?

Our focus is simple: stop Alzheimer’s before it starts. This disease steals the moments that make us who we are and the memories we share. That’s why we believe in attacking Alzheimer’s from every angle — because every breakthrough means more time, more hope and more moments together for families who can’t wait.

Faculty Profile Jan Kubanek (Links to an external site)

Jan Kubanek

Jan Kubanek, PhD, joined the faculty of WashU Medicine Department of Psychiatry on August 1, 2025, as associate professor of psychiatry in the Division of Clinical Neuroscience and Behavioral Health, with secondary appointments in the Department of Neurology and Department of Radiology.  He brings combined experience in human and macaque electrophysiology, human and macaque behavioral […]